PERNA, Alessandra
 Distribuzione geografica
Continente #
EU - Europa 12.494
NA - Nord America 6.128
AS - Asia 5.499
SA - Sud America 910
AF - Africa 66
Continente sconosciuto - Info sul continente non disponibili 7
OC - Oceania 5
Totale 25.109
Nazione #
RU - Federazione Russa 7.569
US - Stati Uniti d'America 6.047
SG - Singapore 1.846
IE - Irlanda 1.314
CN - Cina 1.049
IT - Italia 898
HK - Hong Kong 844
BR - Brasile 772
VN - Vietnam 721
UA - Ucraina 598
GB - Regno Unito 545
DE - Germania 492
IN - India 407
FR - Francia 401
KR - Corea 208
SE - Svezia 181
FI - Finlandia 173
TR - Turchia 168
GR - Grecia 109
JP - Giappone 66
AT - Austria 53
AR - Argentina 51
NL - Olanda 39
CA - Canada 37
BE - Belgio 33
BD - Bangladesh 32
EC - Ecuador 28
MX - Messico 27
IQ - Iraq 23
PL - Polonia 23
PK - Pakistan 19
ZA - Sudafrica 19
ID - Indonesia 18
AE - Emirati Arabi Uniti 14
PH - Filippine 14
SA - Arabia Saudita 14
PE - Perù 13
UZ - Uzbekistan 12
VE - Venezuela 12
CZ - Repubblica Ceca 11
ES - Italia 10
CO - Colombia 9
DK - Danimarca 8
CL - Cile 7
DZ - Algeria 7
MA - Marocco 7
PY - Paraguay 7
CH - Svizzera 6
KE - Kenya 6
UY - Uruguay 6
AL - Albania 5
AZ - Azerbaigian 5
EU - Europa 5
KZ - Kazakistan 5
NP - Nepal 5
RS - Serbia 5
TN - Tunisia 5
AO - Angola 4
AU - Australia 4
DO - Repubblica Dominicana 4
EG - Egitto 4
HN - Honduras 4
LT - Lituania 4
TH - Thailandia 4
BO - Bolivia 3
CY - Cipro 3
ET - Etiopia 3
HR - Croazia 3
MY - Malesia 3
OM - Oman 3
PA - Panama 3
PS - Palestinian Territory 3
SN - Senegal 3
BB - Barbados 2
BY - Bielorussia 2
CI - Costa d'Avorio 2
GA - Gabon 2
GY - Guiana 2
HU - Ungheria 2
JM - Giamaica 2
JO - Giordania 2
KG - Kirghizistan 2
LA - Repubblica Popolare Democratica del Laos 2
MK - Macedonia 2
NO - Norvegia 2
SC - Seychelles 2
A1 - Anonimo 1
BG - Bulgaria 1
CG - Congo 1
CR - Costa Rica 1
EE - Estonia 1
GE - Georgia 1
GI - Gibilterra 1
IL - Israele 1
IR - Iran 1
KW - Kuwait 1
MN - Mongolia 1
NC - Nuova Caledonia 1
NI - Nicaragua 1
PT - Portogallo 1
Totale 25.103
Città #
Moscow 2.710
Dublin 1.308
Jacksonville 910
Hong Kong 831
Singapore 822
Santa Clara 787
Chandler 664
San Jose 571
Bengaluru 353
Ashburn 261
Ho Chi Minh City 228
Chicago 213
Seoul 201
Princeton 179
Hefei 164
Hanoi 161
Medford 159
Bremen 144
Naples 144
Beijing 138
Boardman 126
New York 116
San Mateo 103
Ann Arbor 99
Dallas 97
Caserta 90
Roxbury 83
Istanbul 77
Los Angeles 76
São Paulo 70
Woodbridge 66
Wilmington 63
The Dalles 59
Aversa 54
Da Nang 54
Camerino 45
Lyon 43
Nuremberg 39
Milan 38
Cambridge 34
Des Moines 34
Haiphong 33
London 33
Orem 33
Vienna 33
Dong Ket 30
Brussels 29
Council Bluffs 26
Amsterdam 25
Columbus 24
Rome 24
Munich 21
Atlanta 20
Frankfurt am Main 19
Rio de Janeiro 19
Belo Horizonte 18
Helsinki 18
Napoli 18
Tokyo 18
Hải Dương 17
Nanjing 17
Düsseldorf 16
Casoria 15
Houston 15
Chennai 14
Curitiba 14
Mountain View 14
Warsaw 14
Brooklyn 13
Jinan 13
Norwalk 13
Porto Alegre 13
Tianjin 13
Guangzhou 12
Johannesburg 12
Montreal 12
Ariano Irpino 11
Brasília 11
Guayaquil 11
Jakarta 11
Salvador 11
Zhengzhou 11
Cagliari 10
Denver 10
Dhaka 10
Lima 10
Salerno 10
Stockholm 10
São José dos Campos 10
Tashkent 10
Thái Bình 10
Auburn Hills 9
Baghdad 9
Biên Hòa 9
Brno 9
Can Tho 9
Falkenstein 9
Ninh Bình 9
Quito 9
San Francisco 9
Totale 13.329
Nome #
Potassium depletion induces cellular conversion in the outer medullary collecting duct altering Notch signaling pathway 269
Big databases and biobanks for studying the links between CKD, cognitive impairment, and dementia 204
MicroRNAs in Renal Diseases: A Potential Novel Therapeutic Target 194
ADAM17, a New Player in the Pathogenesis of Chronic Kidney Disease–Mineral and Bone Disorder 191
Hyperhomocysteinemia in Chronic Renal Failure: Alternative Therapeutic Strategies 181
Cognitive impairment in CKD patients: a guidance document by the CONNECT network 179
The gasotransmitter hydrogen sulfide in hemodialysis patients 178
Application of proteomics and metabolomics to study inherited kidney disorders: from big data to precision medicine 178
A case series of adult patients affected by EAST/SeSAME syndrome suggests more severe disease in subjects bearing KCNJ10 truncating mutations 178
miRNA-23a modulates sodium-hydrogen exchanger 1 expression: studies in medullary thick ascending limb of salt induced hypertensive rats 171
Possible Effects of Uremic Toxins p-Cresol, Indoxyl Sulfate, p-Cresyl Sulfate on the Development and Progression of Colon Cancer in Patients with Chronic Renal Failure 168
Altered folate receptor 2 expression in uraemic patients on haemodialysis: Implications for folate resistance 167
D-amino acids in aging erythrocytes. 164
Cytoskeletal behaviour in spectrin and in band 3 deficient spherocytic red cells: Evidence for a differentiated splenic conditioning role 163
Bone composition and the birth of quantitative chemistry 163
Divergent behavior of hydrogen sulfide pools and of the sulfur metabolite lanthionine, a novel uremic toxin, in dialysis patients 162
Atenolol vs enalapril in young hypertensive patients after successful repair of aortic coarctation 161
The Sulfur Metabolite Lanthionine: Evidence for a Role as a Novel Uremic Toxin 161
COVID-19, Low-Molecular-Weight Heparin, and Hemodialysis 161
Renal phenotype in bardet-biedl syndrome: A combined defect of urinary concentration and dilution is associated with defective urinary aqp2 and umod excretion 160
Metabolomic fingerprinting of renal disease progression in Bardet-Biedl syndrome reveals mitochondrial dysfunction in kidney tubular cells. 159
D-aspartate content of erythrocyte membrane proteins is decreased in uremia: Implications for the repair of damaged proteins 159
Atherosclerosis determinants in renal disease: How much is homocysteine involved? 158
Impairment of endothelial functions by acute hyperhomocysteinemia and reversal by antioxidant vitamins 157
Characterization of five novel vasopressin V2 receptor mutants causing nephrogenic diabetes insipidus reveals a role of tolvaptan for M272R-V2R mutation 157
Adverse effects of hyperhomocysteinemia and their management by folic acid 155
Uremic Toxin Lanthionine Interferes with the Transsulfuration Pathway, Angiogenetic Signaling and Increases Intracellular Calcium 155
Fabry Disease in Women: Genetic Basis, Available Biomarkers, and Clinical Manifestations 155
Nephroplex: a kidney-focused NGS panel highlights the challenges of PKD1 sequencing and identifies a founder BBS4 mutation 154
Creatinine clearance and hemoglobin concentration before and after heart transplantation 153
Bone mineral density assessment in patients with cystinuria 152
Long-term function of parathyroid subcutaneous autoimplantation after presumed total parathyroidectomy in the treatment of secondary hyperparathyroidism. A clinical retrospective study 152
The heart in uremia: Role of hypertension, hypotension, and sleep apnea 152
Cardiovascular risk factors, homocysteine and folates 151
Dapagliflozin Prevents Kidney Glycogen Accumulation and Improves Renal Proximal Tubule Cell Functions in a Mouse Model of Glycogen Storage Disease Type 1b 150
Looking beyond Entecavir to discover Gitelman Syndrome in a 50 year-old man 150
A bench to bedside view of uremic toxins 149
Homocysteine solution‐induced response in aerosol jet printed oects by means of gold and platinum gate electrodes 149
[Hyperhomocysteinemia and treatment with folates: what's new?]. 148
Dna methylation dysfunction in chronic kidney disease 148
Impact of Thyroid Cancer Treatment on Renal Function: A Relevant Issue to Be Addressed 147
Translational research on cognitive impairment in chronic kidney disease 147
Anemia and erythropoietin in space flights 147
Candidate risk factors for cardiovascular disease in CKD 145
Lanthionine and Other Relevant Sulfur Amino Acid Metabolites: Detection of Prospective Uremic Toxins in Serum by Multiple Reaction Monitoring Tandem Mass Spectrometry 145
BK Virus Infection and BK-Virus-Associated Nephropathy in Renal Transplant Recipients 145
[Survival is not enough: improving quality of life]. 142
Corrigendum to “WCN24-1267 EMPAGLIFLOZIN IMPROVES VITALITY AND PROTECT FROM ADVANCED GLYCATION END PRODUCTS IN ENDOTHELIAL CELLS” [Kidney International Reports Volume 9, Issue 4, Supplement, April 2024, Page S637] 141
Gases as Uremic Toxins: Is There Something in the Air? 140
Hyperhomocysteinemia in ESRD. 140
[Hyponatremia and Electrolyte Disorders in Cancer Patients] 139
Two different serum MiRNA signatures correlate with the clinical outcome and histological subtype in pleural malignant mesothelioma patients 139
Hydrogen sulfide reduces cell adhesion and relevant inflammatory triggering by preventing ADAM17-dependent TNF-α activation 138
Long-term outcomes following “presumed” total parathyroidectomy for secondary hyperparathyroidism of chronic kidney disease 138
A longitudinal study of sleep disorders in early-stage chronic kidney disease. 138
Hyperhomocysteinemia and protein damage in chronic renal failure and kidney transplant pediatric patients - Italian initiative on uremic hyperhomocysteinemia (IIUH) 137
Impact of the uremic milieu on the osteogenic potential of mesenchymal stem cells 136
Chitosan Gel to Treat Pressure Ulcers: A Clinical Pilot Study 136
Urine concentrating defect as presenting sign of progressive renal failure in Bardet-Biedl syndrome patients 135
Vasodilatation caused by endogenous hydrogen sulfide in chronic renal failure 134
[Health care based on patients' needs]. 134
The SGLT2 inhibitor dapagliflozin improves kidney function in glycogen storage disease XI 133
Zebrafish as a Model of Cardiac Pathology and Toxicity: Spotlight on Uremic Toxins 132
Chemotherapy-related cognitive impairment and kidney dysfunction 131
Does gut microbiota dysbiosis impact the metabolic alterations of hydrogen sulfide and lanthionine in patients with chronic kidney disease? 131
EDEMA IN NEPHROTIC SYNDROME 131
The Giordano-Giovannetti diet 130
INIBIZIONE DELLA METIL-ESTERIFICAZIONE ENZIMATICA DELLE PROTEINE DI MEMBRANA E SUO SIGNIFICATO NELL'UREMIA:RUOLO DELL'OMOCISTEINA 130
The kidney in heart failure 129
Renal function in space: The link between osteoporosis, hypercalciuria, and aquaporins 129
Hydrogen Sulfide, the Third Gaseous Signaling Molecule With Cardiovascular Properties, Is Decreased in Hemodialysis Patients 129
Therapy of Hyperhomocysteinemia in Hemodialysis Patients: Effects of Folates and N-Acetylcysteine 128
Localization of members of MCT monocarboxylate transporter family Slc16 in the kidney and regulation during metabolic acidosis 127
Exploring Key Challenges of Understanding the Pathogenesis of Kidney Disease in Bardet–Biedl Syndrome 127
Uremic Toxin Lanthionine Induces Endothelial Cell Mineralization In Vitro 127
CKD in Bardet-Biedl Syndrome: Evidence Supporting Multifactorial Etiology 126
Homocysteine and transmethylations in uremia 126
Phosphate depletion impairs insulin secretion by pancreatic islets 126
Membrane protein damage and methylation reactions in chronic renal failure 126
Decrease in parathyroid gland volume, but not in parathyroid hormone secretion, after cinacalcet treatment in a 2HPT hemodialysis patient. Case report. 126
Role of parathyroidectomy on anemia control and erythropoiesis-stimulating agent need in secondary hyperparathyroidism of chronic kidney disease. A retrospective study in 30 hemodialysis patients 125
Epigenetics in hyperhomocysteinemic states. A special focus on uremia 125
The nature of water: excerpts from Pythagoras, Xenophanes, Heraclitus and Parmenides 125
Impact of parathyroidectomy on cardiovascular outcomes and survival in chronic hemodialysis patients with secondary hyperparathyroidism. A retrospective study of 50 cases prior to the calcimimetics era 124
Integrin beta 1 is crucial for urinary concentrating ability and renal medulla architecture in adult mice 124
Plasma protein homocysteinylation in uremia 123
Parathyroidectomy improves the quality of sleep in maintenance hemodialysis patients with severe hyperparathyroidism 122
Homocysteinylated albumin promotes increased monocyte-endothelial cell adhesion and up-regulation of MCP1, Hsp60 and ADAM17 122
INSUFFICIENZA RENALE CRONICA 122
Homocysteine and chronic kidney disease: an ongoing narrative 122
The Gut Microbiota in Kidney Transplantation: A Target for Personalized Therapy? 121
To survive is not enough. Quality of life in CKD - The need for a new generation of health-oriented economists 121
Therapeutic Plasmapheresis: a revision of literature 120
Low protein alimentation normalizes renal haemodynamic response to acute protein ingestion in type 1 diabetic children 120
Lab on a Chip Device for Diagnostic Evaluation and Management in Chronic Renal Disease: A Change Promoting Approach in the Patients’ Follow Up 119
Review on uraemic toxins III: Recommendations for handling uraemic retention solutes in vitro - Towards a standardized approach for research on uraemia 119
Plasma proteins containing damaged L-isoaspartyl residues are increased in uremia: Implications for mechanism 119
Increased plasma protein homocysteinylation in hemodialysis patients 119
Homocysteine, a new cardiovascular risk factor, is also a powerful uremic toxin 118
Hyperhomocysteinemia in uremia - A red flag in a disrupted circuit 117
Totale 14.430
Categoria #
all - tutte 79.277
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 79.277


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021458 0 0 0 0 0 0 0 0 0 191 142 125
2021/20221.120 117 10 16 49 391 15 12 24 49 60 77 300
2022/20232.573 220 48 51 213 320 196 9 138 1.214 36 56 72
2023/20241.051 96 33 45 109 356 110 41 32 12 3 71 143
2024/20253.663 123 26 49 199 512 506 607 339 445 489 209 159
2025/202613.353 587 903 630 598 1.026 7.132 992 530 547 408 0 0
Totale 25.447